Recap: Conmed Q4 Earnings

Conmed CNMD reported its Q4 earnings results on Wednesday, January 26, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Conmed beat estimated earnings by 0.94%, reporting an EPS of $1.07 versus an estimate of $1.06, which did not surprise analysts.

Revenue was up $21.14 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04, which was followed by a 4.27% increase in the share price the next day.

Here's a look at Conmed's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate 0.76 0.62 0.44 0.76
EPS Actual 0.80 0.71 0.63 0.84
Revenue Estimate 255.53M 248.31M 216.88M 262.94M
Revenue Actual 248.83M 255.16M 232.68M 252.83M

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Guidance

Conmed management provided guidance for their next quarter, expecting earnings between $3.6 and $3.85 per share for the next quarter.

This represents a 248.13% in quarter-over-quarter growth for Conmed, a bullish signal to many investors.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!